EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants

Laura A Novotny, Carla Martinez-Morant, Stephen A Duncan, Paula Traktman, Monika Gooz, Eric G Meissner

Journal of Innate Immunity · 29.05.2026 · 18 (1) · 315-333

DOI: 10.1159/000552360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Innate Immunity, online erschienen am 29.05.2026. Verfasst von Laura A Novotny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Receptors, Interferon, Hepatocytes, Hepatitis B virus. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Lambda interferons signal through the interferon lambda receptor 1 (IFNLR1) and IL10RB heterodimer to induce interferon stimulated genes (ISGs). We previously showed that proteins derived from distinct IFNLR1 splice isoforms uniquely influence gene expression and hepatitis B virus replication in stem cell-derived hepatocytes (iHeps). Here, we evaluated signal transduction mechanisms of full-length IFNLR1 (variant 1) and a truncated variant missing part of the cytoplasmic JAK1-interacting domain (variant 2).

Methods

We evaluated HEK293T cells, wild-type (WT), and IFNLR1 knockout (KO) iHeps with doxycycline-inducible expression of FLAG-tagged IFNLR1 variants using the Duolink proximity ligation assay, ImageStream flow cytometry, Western blotting, susceptibility to JAK1 and TYK2 inhibitors, and gene expression profiling.

Results

Each variant colocalized with IL10RB after IFNL3 treatment, but variant 1 was more rapidly and extensively internalized. In WT iHeps, overexpression of variant 1 or variant 2 enabled higher IFNL-induced JAK1, TYK2, STAT1, and STAT2 phosphorylation, yet variant 2 supported less robust ISG induction. In KO iHeps, variant 2 supported less JAK1 and TYK2 phosphorylation and ISG induction than variant 1, yet supported comparable STAT1 and STAT2 phosphorylation. In iHeps expressing variant 1, WT iHeps were more resistant than KO iHeps to TYK2 inhibition of antiviral ISG induction, yet were more susceptible to TYK2 inhibition of proinflammatory ISG induction, suggesting endogenous noncanonical variants influence TYK2-signaling dependence.

Conclusion

IFNLR1 variants promote differential utilization of signaling mediators to influence IFNL-induced gene expression patterns, indicating a putative role in pathway regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, InterferonHepatocytesHepatitis B virusHumansSignal TransductionTYK2 KinaseJanus Kinase 1STAT1 Transcription FactorHEK293 CellsInterleukin-10 Receptor beta SubunitInterferonsProtein IsoformsSTAT2 Transcription FactorPhosphorylationGene Expression RegulationInterferon LambdaInterleukinsVirus Replication

Stichwörter der Autor:innen

Interferon lambda receptor 1JAK1Lambda interferonReceptor variantsTYK2

Substanzen

Receptors, InterferonIFNLR1 protein, humanTYK2 KinaseJanus Kinase 1STAT1 Transcription FactorTYK2 protein, humanInterleukin-10 Receptor beta SubunitInterferonsProtein IsoformsSTAT1 protein, human

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA, meissner@musc.edu.
  • Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina, USA, meissner@musc.edu.

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Novotny, L. A., Martinez-Morant, C., Duncan, S. A., Traktman, P., Gooz, M., & Meissner, E. G. (2026). Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants. Journal of Innate Immunity, 18(1), 315-333. https://doi.org/10.1159/000552360

Vancouver

Novotny LA, Martinez-Morant C, Duncan SA, Traktman P, Gooz M, Meissner EG. Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants. Journal of Innate Immunity. 2026;18(1):315-333. doi:10.1159/000552360

BibTeX
@article{Novotny2026,
  author = {Novotny, Laura A and Martinez-Morant, Carla and Duncan, Stephen A and Traktman, Paula and Gooz, Monika and Meissner, Eric G},
  title = {Mechanisms of Differential Signal Transduction by Interferon Lambda Receptor 1 Variants},
  journal = {Journal of Innate Immunity},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {315--333},
  doi = {10.1159/000552360}
}
Kostenlos starten →